100,000 Shares in Veeva Systems Inc. $VEEV Acquired by Alfreton Capital LLP

Alfreton Capital LLP bought a new position in Veeva Systems Inc. (NYSE:VEEV) in the fourth quarter, according to its most recent filing with the SEC. The firm bought 100,000 shares of the technology company’s stock, valued at approximately $22,323,000. Veeva Systems makes up 9.4% of Alfreton Capital LLP’s investment portfolio, making the stock its 4th largest position.

A number of other institutional investors also recently bought and sold shares of VEEV. GPS Wealth Strategies Group LLC lifted its stake in Veeva Systems by 196.4% during the 3rd quarter. GPS Wealth Strategies Group LLC now owns 83 shares of the technology company’s stock valued at $25,000 after acquiring an additional 55 shares during the period. Board of the Pension Protection Fund acquired a new stake in Veeva Systems during the 4th quarter valued at approximately $27,000. Raiffeisen Bank International AG acquired a new stake in Veeva Systems during the 3rd quarter valued at approximately $28,000. Newbridge Financial Services Group Inc. lifted its stake in Veeva Systems by 322.6% during the 4th quarter. Newbridge Financial Services Group Inc. now owns 131 shares of the technology company’s stock valued at $29,000 after acquiring an additional 100 shares during the period. Finally, Activest Wealth Management lifted its stake in shares of Veeva Systems by 3,175.0% in the 4th quarter. Activest Wealth Management now owns 131 shares of the technology company’s stock valued at $29,000 after purchasing an additional 127 shares during the period. 88.20% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the stock. Oppenheimer decreased their target price on shares of Veeva Systems from $275.00 to $225.00 and set an “outperform” rating for the company in a research note on Monday, May 18th. Royal Bank Of Canada decreased their target price on shares of Veeva Systems from $330.00 to $275.00 and set an “outperform” rating for the company in a research note on Thursday, March 5th. Morgan Stanley boosted their price target on shares of Veeva Systems from $205.00 to $215.00 and gave the stock an “equal weight” rating in a report on Thursday, March 5th. Canaccord Genuity Group cut their price target on shares of Veeva Systems from $280.00 to $235.00 and set a “hold” rating for the company in a report on Thursday, March 5th. Finally, William Blair reissued an “outperform” rating on shares of Veeva Systems in a report on Tuesday, March 10th. Sixteen research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $276.52.

Trending Headlines about Veeva Systems

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Veeva announced that Kindeva, a global CDMO, is adopting Veeva Quality Cloud to unify sites on a single platform, which supports Veeva’s growth narrative and could boost future recurring software revenue. Why Veeva Systems (VEEV) Stock Is Up Today
• Positive Sentiment: Coverage highlighting Veeva versus IQVIA points to strong industry tailwinds from life sciences digitization, with Veeva viewed as benefiting from AI adoption and a premium business model. Veeva vs. IQVIA: Which Life Sciences Tech Stock Holds More Promise?
• Neutral Sentiment: Several articles previewed Wall Street’s key metric estimates for Veeva’s upcoming quarter, suggesting investors are watching whether the company can meet growth expectations, but these pieces did not include a new earnings surprise or guidance update. Unveiling Veeva (VEEV) Q1 Outlook: Wall Street Estimates for Key Metrics
• Neutral Sentiment: Veeva was also highlighted as a trending stock and covered in analyst-style writeups noting a “Moderate Buy” consensus, which supports attention on the name but does not by itself change fundamentals. Veeva Systems Inc. (NYSE:VEEV) Given Average Recommendation of “Moderate Buy” by Analysts

Insider Activity

In other news, Director Priscilla Hung sold 750 shares of the firm’s stock in a transaction that occurred on Thursday, April 30th. The shares were sold at an average price of $155.64, for a total transaction of $116,730.00. Following the transaction, the director directly owned 3,253 shares in the company, valued at approximately $506,296.92. This trade represents a 18.74% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 10.60% of the company’s stock.

Veeva Systems Stock Performance

VEEV stock opened at $173.97 on Friday. The company’s 50 day moving average price is $166.38 and its 200 day moving average price is $199.77. Veeva Systems Inc. has a fifty-two week low of $148.05 and a fifty-two week high of $310.50. The firm has a market capitalization of $28.42 billion, a price-to-earnings ratio of 32.16, a PEG ratio of 0.73 and a beta of 0.92.

Veeva Systems (NYSE:VEEV) last released its earnings results on Wednesday, March 4th. The technology company reported $2.06 earnings per share for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. The firm had revenue of $835.95 million for the quarter, compared to analyst estimates of $810.95 million. Veeva Systems had a net margin of 28.44% and a return on equity of 13.80%. The business’s quarterly revenue was up 16.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.74 earnings per share. Veeva Systems has set its FY 2027 guidance at 8.850- EPS and its Q1 2027 guidance at 2.130-2.14 EPS. Equities analysts forecast that Veeva Systems Inc. will post 6.45 EPS for the current fiscal year.

About Veeva Systems

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.